| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,034 |
2,550 |
$407K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,337 |
1,840 |
$372K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
943 |
715 |
$165K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
877 |
701 |
$74K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
395 |
320 |
$57K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,698 |
1,381 |
$48K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
834 |
754 |
$38K |
| G0378 |
Hospital observation service, per hour |
225 |
168 |
$37K |
| 71045 |
Radiologic examination, chest; single view |
1,207 |
921 |
$36K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
545 |
425 |
$36K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,051 |
787 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,396 |
1,054 |
$27K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
915 |
658 |
$25K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
801 |
601 |
$20K |
| 87400 |
|
2,968 |
1,202 |
$19K |
| 70450 |
Computed tomography, head or brain; without contrast material |
534 |
443 |
$18K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
497 |
322 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
657 |
578 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
269 |
123 |
$14K |
| 80053 |
Comprehensive metabolic panel |
2,605 |
1,903 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,847 |
1,918 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
118 |
102 |
$6K |
| 84484 |
|
1,152 |
801 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
131 |
108 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
68 |
55 |
$5K |
| 81025 |
|
716 |
616 |
$4K |
| 87428 |
|
87 |
76 |
$3K |
| 83880 |
|
265 |
193 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
29 |
24 |
$2K |
| 83735 |
|
755 |
566 |
$2K |
| 83605 |
|
439 |
339 |
$2K |
| 83690 |
|
596 |
483 |
$2K |
| 73630 |
|
47 |
43 |
$2K |
| 81003 |
|
1,656 |
1,344 |
$2K |
| 73610 |
|
33 |
28 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
72 |
65 |
$2K |
| 73560 |
|
31 |
26 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
31 |
24 |
$1K |
| 87634 |
|
20 |
20 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
199 |
163 |
$1K |
| 85379 |
|
292 |
227 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
53 |
35 |
$1K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
17 |
13 |
$845.58 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
12 |
$721.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
312 |
185 |
$695.58 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
149 |
114 |
$520.22 |
| 85610 |
|
326 |
252 |
$456.76 |
| 82803 |
|
60 |
43 |
$424.35 |
| 85732 |
|
139 |
109 |
$315.76 |
| 87807 |
|
19 |
19 |
$165.18 |
| 81001 |
|
81 |
69 |
$128.25 |
| 87040 |
|
18 |
12 |
$92.90 |
| 36415 |
Collection of venous blood by venipuncture |
18 |
15 |
$69.58 |
| 82962 |
|
42 |
21 |
$48.21 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
785 |
530 |
$36.96 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
627 |
524 |
$5.50 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
18 |
12 |
$4.32 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
561 |
428 |
$4.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
54 |
48 |
$1.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
110 |
81 |
$1.06 |
| A9270 |
Non-covered item or service |
4,354 |
1,764 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
21 |
12 |
$0.00 |
| 96376 |
|
94 |
58 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
688 |
561 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
130 |
96 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
118 |
84 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
50 |
37 |
$0.00 |